chr17-68600628-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_017565.4(FAM20A):c.39G>A(p.Leu13Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0398 in 1,560,538 control chromosomes in the GnomAD database, including 2,187 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.040 ( 189 hom., cov: 32)
Exomes 𝑓: 0.040 ( 1998 hom. )
Consequence
FAM20A
NM_017565.4 synonymous
NM_017565.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.76
Publications
5 publications found
Genes affected
FAM20A (HGNC:23015): (FAM20A golgi associated secretory pathway pseudokinase) This locus encodes a protein that is likely secreted and may function in hematopoiesis. A mutation at this locus has been associated with amelogenesis imperfecta and gingival hyperplasia syndrome. Alternatively spliced transcript variants have been identified. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 17-68600628-C-T is Benign according to our data. Variant chr17-68600628-C-T is described in ClinVar as Benign. ClinVar VariationId is 260832.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.76 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.146 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0402 AC: 6117AN: 152126Hom.: 188 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
6117
AN:
152126
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0525 AC: 8449AN: 161032 AF XY: 0.0586 show subpopulations
GnomAD2 exomes
AF:
AC:
8449
AN:
161032
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0398 AC: 56044AN: 1408296Hom.: 1998 Cov.: 33 AF XY: 0.0426 AC XY: 29695AN XY: 696574 show subpopulations
GnomAD4 exome
AF:
AC:
56044
AN:
1408296
Hom.:
Cov.:
33
AF XY:
AC XY:
29695
AN XY:
696574
show subpopulations
African (AFR)
AF:
AC:
1446
AN:
32652
American (AMR)
AF:
AC:
528
AN:
37674
Ashkenazi Jewish (ASJ)
AF:
AC:
593
AN:
25272
East Asian (EAS)
AF:
AC:
5420
AN:
37742
South Asian (SAS)
AF:
AC:
11633
AN:
80652
European-Finnish (FIN)
AF:
AC:
1290
AN:
40912
Middle Eastern (MID)
AF:
AC:
182
AN:
4278
European-Non Finnish (NFE)
AF:
AC:
32496
AN:
1090482
Other (OTH)
AF:
AC:
2456
AN:
58632
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
3335
6670
10004
13339
16674
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1392
2784
4176
5568
6960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0402 AC: 6122AN: 152242Hom.: 189 Cov.: 32 AF XY: 0.0432 AC XY: 3213AN XY: 74428 show subpopulations
GnomAD4 genome
AF:
AC:
6122
AN:
152242
Hom.:
Cov.:
32
AF XY:
AC XY:
3213
AN XY:
74428
show subpopulations
African (AFR)
AF:
AC:
1857
AN:
41572
American (AMR)
AF:
AC:
335
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
AC:
90
AN:
3472
East Asian (EAS)
AF:
AC:
573
AN:
5126
South Asian (SAS)
AF:
AC:
751
AN:
4828
European-Finnish (FIN)
AF:
AC:
418
AN:
10614
Middle Eastern (MID)
AF:
AC:
11
AN:
292
European-Non Finnish (NFE)
AF:
AC:
1998
AN:
68002
Other (OTH)
AF:
AC:
79
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
288
575
863
1150
1438
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
412
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.